LSI USA '23 filling fast. Register Now

Gala Therapeutics (Acquired)

Procedure designed to directly treat the abnormal airway cells responsible for chronic bronchitis, with additional applications in lung cancer, COPD,...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Gala Therapeutics (Acquired) plus 5343 other startups.

Start Free 7 Day Trial Now

Learn More About Gala Therapeutics (Acquired)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

Competing Startups

More

Our Clients